Medtronic plc — News

Orchestra BioMed is approaching pivotal trial readouts for AVIM Therapy and Virtue SAB, both with strong success potential. OBIO operates as an innovation and clinical development platform for medical devices, relying on Medtronic and Terumo for commercialization. Medtronic and Terumo have invested a combined $146 million, with OBIO's $220 million valuation reflecting a modest premium to strategic funding and with significant potential upside as catalysts approach.

seekingalpha.com - 2026-07-22 12:06:45

Medtronic (MDT) reached $82.35 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.

zacks.com - 2026-07-21 18:51:05

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery GALWAY, Ireland, July 21, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, is presenting an early look at its next-generation compute platform for the operating room. Touch Surgery™ Aide — an AI-native surgical computing platform that powers the Touch Surgery™ ecosystem — enables real-time artificial intelligence during procedures.

prnewswire.com - 2026-07-21 07:00:00

Andra AP fonden lowered its stake in Medtronic PLC (NYSE: MDT) by 3.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 253,329 shares of the medical technology company's stock after selling 10,400 shares during the quarter. Andra AP fonden's holdings in

defenseworld.net - 2026-07-21 03:19:20

GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026. A news release containing summary financial information will be issued at 5:45 a.m.

prnewswire.com - 2026-07-20 07:00:00

Decker Wealth Management LLC bought a new position in shares of Medtronic PLC (NYSE: MDT) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 58,614 shares of the medical technology company's stock, valued at approximately $5,079,000. Other

defenseworld.net - 2026-07-20 04:33:04

Allspring Global Investments Holdings LLC cut its stake in Medtronic PLC (NYSE: MDT) by 16.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 885,098 shares of the medical technology company's stock after selling 178,782 shares during the quarter. Allspring Global

defenseworld.net - 2026-07-18 03:09:48

Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹ GALWAY, Ireland, July 16, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management.

prnewswire.com - 2026-07-16 09:00:00

Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.

zacks.com - 2026-07-10 18:51:12

I initiate coverage on Medtronic, highlighting its status as a leading medtech name with premium margins. MDT offers an attractive diversification opportunity, combining consistent performance with accelerated revenue growth. The stock trades at undervalued levels, supporting a long-term bullish thesis and a defensive investment approach.

seekingalpha.com - 2026-07-10 11:16:35

Medtronic plc is rated buy with a $92 price target, reflecting conservative fiscal 2027 guidance and resilient growth platforms. Fiscal 2026 delivered $36.4B in revenue, the strongest growth in a decade, led by Cardiovascular and ablation solutions outpacing market rates. Guidance for fiscal 2027 excludes potential catalysts—MiniMed separation, tariff refunds, and Blackstone payment relief—implying room for upside surprises.

seekingalpha.com - 2026-07-10 06:32:24

Medtronic is a dividend aristocrat with a near-decade high yield, making it an attractive long-term income opportunity. The company is experiencing strong revenue growth, driven by its leading positions in cardiovascular and neuroscience medical devices. While current free cash flow payout ratios are sustainable, investors should monitor future dividend growth rates closely.

seekingalpha.com - 2026-07-09 08:32:23

AbbVie is hitting its stride now that it has transitioned past Humira's patent expiration. Medtronic is a steady dividend payer with some intriguing upside in robotics-assisted surgery.

fool.com - 2026-07-07 10:45:00

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-07-03 12:31:08

Medtronic (MDT) reached $78.23 at the closing of the latest trading day, reflecting a -3.34% change compared to its last close.

zacks.com - 2026-06-30 18:51:09

On June 30, 2026, Medtronic PLC (MDT) shares fell 3.3% today, bringing the current price to $78.23. The stock has traded between $73.31 and $106.33 over the pas

gurufocus.com - 2026-06-30 17:12:00

Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside may give it the edge despite a richer valuation.

zacks.com - 2026-06-29 14:41:17

These healthcare leaders have encountered challenges in recent years. However, they are slowly improving their businesses, partly through innovation.

fool.com - 2026-06-23 16:30:00

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

zacks.com - 2026-06-22 10:31:07

Medtronic offers high growth potential in addition to discounted valuation.

barrons.com - 2026-06-18 07:01:00

These stocks pay between 2.9% and 5.2% in dividends. Their low beta values indicate that they don't follow the market too closely.

fool.com - 2026-06-17 11:00:00

Investors need to pay close attention to MDT stock based on the movements in the options market lately.

zacks.com - 2026-06-16 11:26:08

These three healthcare leaders are slowly overcoming recent obstacles. They have strong dividend track records and the means to maintain healthy dividend growth.

fool.com - 2026-06-16 06:15:00

For an investor in their 50s or 60s who is finished chasing trends, Medtronic (NYSE:MDT | MDT Price Prediction) is a stock worth owning for decades because it pairs inelastic demand for medical devices with a 49th consecutive year of dividend increases.

247wallst.com - 2026-06-14 10:57:33

In this article series, I summarize dividend announcements of the past week. Six stocks in my database announced dividend increases, including one stock I own, and one declared a special dividend. W. R. Berkley stands out with an 11.1% dividend increase, a 50¢ special dividend, and the highest quality score this week. Medtronic offers the most value, trading 9% below fair value, but its dividend growth is modest at 1.4%.

seekingalpha.com - 2026-06-13 03:30:57

Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow GALWAY, Ireland, June 12, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of Scientia Vascular, a privately-held medical device company in Salt Lake City. The acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition.

prnewswire.com - 2026-06-12 11:00:00

MDT is betting on ablation, robotics and hypertension therapies as next growth drivers, but tariffs, FX and pricing pressures cloud near-term upside.

zacks.com - 2026-06-11 09:51:19

MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.

zacks.com - 2026-06-10 10:21:04

Even the hottest AI stocks won't win forever. Diversification is the key to long-term wealth.

fool.com - 2026-06-10 04:05:00

Tech stocks are pulling back, and healthcare is surging.

investopedia.com - 2026-06-09 18:06:29

Medtronic plc is a sleepy Dividend Aristocrat with the potential for dividend growth to reaccelerate in the next 12 to 24 months. MDT beat the analyst consensus for revenue and non-GAAP EPS in Q4 2026, with the highest annual revenue growth in 10 years. Medtronic sports an A S&P credit rating with a stable outlook.

seekingalpha.com - 2026-06-08 17:49:28

Medtronic recently reported strong results, highlighting impressive growth.

fool.com - 2026-06-08 10:30:00

Medtronic's Hugo robotic-assisted surgery platform is approved in the U.S. for urologic procedures, and has more applications pending. Intuitive Surgical's da Vinci is the market's flagship platform, and will be difficult to overtake at this point.

fool.com - 2026-06-08 07:21:00

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

seekingalpha.com - 2026-06-05 18:19:56

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

zacks.com - 2026-06-05 10:31:11

Lowe's, Medtronic, and UnitedHealth Group have been solid dividend growth stocks over the years. They offer above-average payouts and their valuations are also attractive.

fool.com - 2026-06-05 08:00:00

On Wednesday, Medtronic plc (NYSE:MDT) reported fourth-quarter revenue that exceeded Wall Street expectations, supported by strong growth in its Cardiovascular and Diabetes businesses.

benzinga.com - 2026-06-04 14:53:22

Medtronic's NYSE: MDT primary catalyst as mid-year approaches is that headwinds are not impairing results as much as feared. Rising costs, margin compression, and general uncertainty linked to macroeconomic headwinds were reflected in the company's June 3 earnings results, but the results were inherently strong and expected to remain so.

marketbeat.com - 2026-06-04 13:10:27

MDT touts FY26 as a turning point, keeps FY27 growth targets high, and spotlights CAS and new platforms as investors press on tariffs and TAVR.

zacks.com - 2026-06-04 05:40:29

Medtronic plc (MDT) Q4 2026 Earnings Call Transcript

seekingalpha.com - 2026-06-03 15:32:01

Revenue: $9.8 billion in Q4, up 9.9% reported and 6.6% organically; $36.4 billion for FY26, up 8.4% reported and 5.8% organically.Adjusted EPS: $1.55 for Q4 an

gurufocus.com - 2026-06-03 14:00:00

Medtronic just wrapped up its best year in a decade.

fool.com - 2026-06-03 13:57:08

Medtronic (MDT) shares are on the rise following a robust fiscal Q4 performance and an optimistic FY27 growth forecast. Although the company's full-year EPS gu

gurufocus.com - 2026-06-03 12:14:00

MDT tops Q4 revenue and earnings estimates as Cardiovascular strength and Cardiac Ablation growth fuel results, while FY27 guidance points higher.

zacks.com - 2026-06-03 11:46:19

Between JOLTS yesterday and ADP this morning, the labor market looks back on track.

zacks.com - 2026-06-03 11:40:54

While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended April 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-06-03 10:30:20

Medtronic has undergone a business revamp and is now ready to grow again, including by leaning into acquisitions.

fool.com - 2026-06-03 09:44:01

Stock futures are sluggish after yesterday's record rally while unpack jobs data and Iran developments

schaeffersresearch.com - 2026-06-03 09:18:00

Medtronic NYSE: MDT reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations.

marketbeat.com - 2026-06-03 09:05:34

Medtronic (MDT) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.62 per share a year ago.

zacks.com - 2026-06-03 08:55:10